Glaub Kathleen Sereda 4
4 · IO Biotech, Inc. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Glaub Kathleen Sereda
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-05+35,144→ 35,144 totalExercise: $1.50Exp: 2035-06-05→ Common Stock (35,144 underlying)
Footnotes (1)
- [F1]These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.